Financial statements Biosys Polska
Balance sheet data of BIOSYS POLSKA
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 846 874,56 | 482 397,22 | 583 526,03 | 660 946,86 | 948 946,65 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 846 874,56 | 482 397,22 | 583 526,03 | 660 946,86 | 948 946,65 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 846 874,56 | 482 397,22 | 583 526,03 | 660 946,86 | 948 946,65 |
| A. Equity | 736 671,12 | 392 766,68 | 416 899,73 | 614 182,83 | 765 974,65 |
| B. Liabilities and provisions for liabilities | 110 203,44 | 89 630,54 | 186 289,30 | 46 764,03 | 182 972,00 |
| I. Long-term liabilities | 6 038,26 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 104 165,18 | 89 630,54 | 186 289,30 | 46 764,03 | 182 972,00 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.